Blau Farmacêutica S.A
Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceutical… Read more
Market Cap & Net Worth: Blau Farmacêutica S.A (BLAU3)
Blau Farmacêutica S.A (SA:BLAU3) has a market capitalization of $290.01 Million (R$1.77 Billion) as of March 18, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #21390 globally and #188 in its home market, demonstrating a -8.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Blau Farmacêutica S.A's stock price R$9.94 by its total outstanding shares 177680739 (177.68 Million).
Blau Farmacêutica S.A Market Cap History: 2021 to 2026
Blau Farmacêutica S.A's market capitalization history from 2021 to 2026. Data shows change from $978.94 Million to $290.01 Million (-23.79% CAGR).
Blau Farmacêutica S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Blau Farmacêutica S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.22x
Blau Farmacêutica S.A's market cap is 0.22 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.77x
Blau Farmacêutica S.A's market cap is 1.77 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $978.94 Million | $1.37 Billion | $325.22 Million | 0.72x | 3.01x |
| 2022 | $729.32 Million | $1.41 Billion | $363.37 Million | 0.52x | 2.01x |
| 2023 | $463.32 Million | $1.37 Billion | $249.81 Million | 0.34x | 1.85x |
| 2024 | $383.66 Million | $1.75 Billion | $217.21 Million | 0.22x | 1.77x |
Competitor Companies of BLAU3 by Market Capitalization
Companies near Blau Farmacêutica S.A in the global market cap rankings as of March 18, 2026.
Key companies related to Blau Farmacêutica S.A by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Blau Farmacêutica S.A Historical Marketcap From 2021 to 2026
Between 2021 and today, Blau Farmacêutica S.A's market cap moved from $978.94 Million to $ 290.01 Million, with a yearly change of -23.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$290.01 Million | -29.25% |
| 2025 | R$409.92 Million | +6.84% |
| 2024 | R$383.66 Million | -17.19% |
| 2023 | R$463.32 Million | -36.47% |
| 2022 | R$729.32 Million | -25.50% |
| 2021 | R$978.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Blau Farmacêutica S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $290.01 Million USD |
| MoneyControl | $290.01 Million USD |
| MarketWatch | $290.01 Million USD |
| marketcap.company | $290.01 Million USD |
| Reuters | $290.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.